Kromek Group (KMK) CMD 2025 summary

Strategic growth pillars and market positioning

• Two core business segments: Advanced Imaging (AI) and CBRN Detection, each with distinct customer bases, growth models, and tailored solutions for high-growth markets.

• Advanced Imaging leverages proprietary CZT technology for OEM supply in medical, security, and industrial applications, with a $400M annual TAM and sole supplier status in key markets.

• CBRN Detection targets a $1B+ TAM, serving distributed end-users in defense, security, and nuclear sectors, with products for radiation and biological threat detection.

• High barriers to entry in both segments due to proprietary IP, deep customer relationships, and incumbency.

• Strategy emphasizes organic growth, disciplined M&A for profitable, synergistic CBRN acquisitions, and reinvestment to expand market presence.

Financial performance and guidance

• FY2025 expected to be transformational, with revenue projected above £26M (>30% growth) and a shift to positive PBT (>£1.8M), compared to prior years of losses.

• Siemens contract ($37.5M) significantly strengthened the balance sheet, with $25M cash received and revenue recognized over four years.

• Gross margin improved from 46.7% in FY22 to 55.2% in FY24, with both divisions expected to drive continued growth and profitability.

• Divisional reporting introduced for greater transparency, with a roughly 50/50 revenue split between AI and CBRN, though FY25 is weighted toward Advanced Imaging due to a major enablement deal.

• Medium-term targets include >£60M revenue, c30% EBITDA margin, and c20% revenue CAGR.

Market trends, opportunities, and growth drivers

• Advanced Imaging benefits from global healthcare trends: aging populations, cost pressures, and demand for better diagnostics, with CZT adoption in SPECT and CT imaging accelerating.

• SPECT and CT combined represent a multi-billion dollar market, with significant contracts secured with Siemens Healthineers and Spectrum Dynamics.

• CBRN Detection driven by geopolitical instability, increased defense spending, nuclear energy expansion, and rising security threats.

• Biological detection solutions are miniaturized, automated, scalable, and supported by government-funded R&D.

• Multiple growth avenues include new product launches, expanded customer base, and post-election market opportunities in CBRN.